Trade Beam Therapeutics Inc. - BEAM CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.13 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 16.56 |
| Open | 16.63 |
| 1-Year Change | -35.04% |
| Day's Range | 16.53 - 17.06 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 17, 2025 | 16.94 | 0.43 | 2.60% | 16.51 | 17.11 | 16.38 |
| Apr 16, 2025 | 16.56 | -0.29 | -1.72% | 16.85 | 16.85 | 15.97 |
| Apr 15, 2025 | 17.21 | 0.56 | 3.36% | 16.65 | 17.78 | 16.65 |
| Apr 14, 2025 | 16.94 | 0.98 | 6.14% | 15.96 | 17.12 | 15.69 |
| Apr 11, 2025 | 15.40 | 0.90 | 6.21% | 14.50 | 15.54 | 14.50 |
| Apr 10, 2025 | 14.58 | -0.97 | -6.24% | 15.55 | 15.55 | 13.92 |
| Apr 9, 2025 | 16.32 | 2.22 | 15.74% | 14.10 | 16.97 | 13.48 |
| Apr 8, 2025 | 14.46 | -1.59 | -9.91% | 16.05 | 16.05 | 13.93 |
| Apr 7, 2025 | 15.23 | 0.79 | 5.47% | 14.44 | 15.90 | 13.47 |
| Apr 4, 2025 | 15.19 | -0.58 | -3.68% | 15.77 | 16.55 | 14.65 |
| Apr 3, 2025 | 16.39 | -0.44 | -2.61% | 16.83 | 17.40 | 16.24 |
| Apr 2, 2025 | 18.40 | 1.23 | 7.16% | 17.17 | 19.07 | 17.09 |
| Apr 1, 2025 | 17.57 | -1.63 | -8.49% | 19.20 | 19.20 | 17.49 |
| Mar 31, 2025 | 19.46 | -1.66 | -7.86% | 21.12 | 21.19 | 18.24 |
| Mar 28, 2025 | 22.13 | -0.34 | -1.51% | 22.47 | 22.78 | 21.65 |
| Mar 27, 2025 | 22.11 | 0.37 | 1.70% | 21.74 | 22.55 | 21.50 |
| Mar 26, 2025 | 21.84 | -1.14 | -4.96% | 22.98 | 23.07 | 21.70 |
| Mar 25, 2025 | 23.16 | -0.69 | -2.89% | 23.85 | 23.85 | 22.57 |
| Mar 24, 2025 | 23.94 | 0.49 | 2.09% | 23.45 | 24.44 | 23.40 |
| Mar 21, 2025 | 23.24 | 0.67 | 2.97% | 22.57 | 23.36 | 22.07 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Beam Therapeutics Inc. Company profile
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children''s Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.| Industry: | Biotechnology & Medical Research (NEC) |
26 Landsdowne St
CAMBRIDGE
MASSACHUSETTS 02139-4216
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com